Brought to you by www.DealSearchOnline.com Week ending April 24, 2015: Recent Health Care M&A Deals Acquirer Target Price Biotechnology Roche License to immune-oncology drug $25 million Celgene Corporation Collaboration on MEDI4736 $450 million Astellas Pharma,...
IMMEDIATE RELEASE Lisa E. Phillips, Editor Stephen M. Monroe, Partner 800-248-1668 203-846-6800 Fax: 203-846-8300 pressreleases@levinassociates.com NORWALK, CT – April 17, 2015 – Health care merger and acquisition activity continued to grow in the first quarter...
A quarterly event for SeniorCare Investor subscribers On Thursday April 9, 2015, The SeniorCare Investor hosted the second meeting of The Members Breakfast, a quarterly event exclusively for SCI subscribers. Each event is designed for our subscribers to not only...
Email Whitelisting Not receiving our newsletters? If you currently use an anti-spam program or service, we ask that you take just a minute to “white list” us, which simply means to add our publication to your “safe” or allowed email sender list....
Bringing You Senior Care M&A Deals and News April 15, 2015 Issue: Seniors Housing Weekly Update: 60 Seconds with Steve Monroe The Ventas Spin-off Has People Talking: There are differing opinions as to what motivated Ventas to spin out most of its skilled...
Brought to you by www.DealSearchOnline.com Week ending April 10, 2015: Recent Health Care M&A Deals Acquirer Target Price Biotechnology Protea Biosciences Group, Inc. vivoPharm Pty Ltd. N/A Agenus Inc. Celexion antibody assets $4 million Labs, MRI & DIalysis...